Trials / Unknown
UnknownNCT04699175
A Trial of HR021618 in Postsurgical Pain Management
A Phase Ⅱ, Multicenter, Randomized, Single-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy of HR021618 for Pain Management Following Orthopaedic Surgery
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, safety of HR021618 and to explore the reasonable dosage of HR021618 for Pain Management after Orthopaedic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR021618 | Treatment group A:HR021618; high dose |
| DRUG | HR021618 | Treatment group B:HR021618; low dose |
| DRUG | Placebo | Treatment group C: HR021618 blank preparation. |
Timeline
- Start date
- 2020-12-17
- Primary completion
- 2021-08-03
- Completion
- 2021-08-08
- First posted
- 2021-01-07
- Last updated
- 2021-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04699175. Inclusion in this directory is not an endorsement.